Literature DB >> 26722536

Cancer burden in China from 2006 to 2010.

Xuefei Zhang1, Yizhong Yan1, Shugang Li1, Feng Li2, Zhenzhen Wan1, Lijuan Pang2, Shuxia Guo1, Qiang Niu1, Shangzhi Xu1, Honglian Xiang1, Rong Ma1, Jinpo Zheng1, Jiangyan Xian1.   

Abstract

OBJECTIVE: To investigate the incidence, mortality, and disease burden of cancer in China to provide a reference for cancer prevention and control.
METHODS: Cancer registry data (2006-2010) were collected from the Chinese Cancer Registry Annual Report by the National Center for Cancer Registries. Cancer incidence and mortality, potential years of life lost (PYLL), and disability-adjusted life years (DALYs) were calculated.
RESULTS: The cancer incidence rate was 267.13/100,000 overall, 299.13/100,000 in men, and 234.06/100,000 in women (1.2 times higher in men than in women). The cancer mortality rate was 176.32/100,000 overall, 220.54/100,000 in men, and 130.60/100,000 in women (1.6 times higher in men than in women). The incidence rate was higher in urban areas (285.97/100,000) than in rural areas (250.91/100,000), whereas the mortality rate was higher in rural areas (179.25/100,000) than in urban areas (172.91/100,000). The rural: urban incidence ratio decreased from 0.89 in 2006 to 0.69 in 2010, and the rural: urban mortality ratio decreased from 1.10 to 0.91 in the same years. PYLL rates and DALY rates were higher in men (16.45 and 22.19, respectively) than in women (11.22 and 13.87, respectively) and in rural areas (17.6 and 22.17, respectively) than in urban areas (12.6 and 17.09, respectively). The male: female ratios for PYLL and DALY rates were 1.46 and 1.6, respectively. The rural: urban ratios for PYLL and DALY rates decreased from 1.63 in 2006 to 1.22 in 2010 and from 1.51 in 2006 to 1.08 in 2010, respectively.
CONCLUSION: The disease burden of cancer in China in 2006-2010 was substantial, particularly for men and residents of rural districts.

Entities:  

Keywords:  China; Incidence; burden of disease; cancer; mortality

Mesh:

Year:  2015        PMID: 26722536      PMCID: PMC4680481     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  37 in total

1.  Years of potential life lost (YPLL)--what does it measure?

Authors:  J W Gardner; J S Sanborn
Journal:  Epidemiology       Date:  1990-07       Impact factor: 4.822

2.  China: awakening giant developing solutions to population aging.

Authors:  Ning Jackie Zhang; Man Guo; Xiaoying Zheng
Journal:  Gerontologist       Date:  2012-08-30

3.  GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology.

Authors:  Christopher J L Murray; Majid Ezzati; Abraham D Flaxman; Stephen Lim; Rafael Lozano; Catherine Michaud; Mohsen Naghavi; Joshua A Salomon; Kenji Shibuya; Theo Vos; Alan D Lopez
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

4.  Colorectal cancer in young and elderly patients.

Authors:  Maciej Berut; Michał Mik; Renata Kędzia-Berut; Ryszard Kujawski; Radzisław Trzciński; Łukasz Dziki; Adam Dziki
Journal:  Pol Przegl Chir       Date:  2013-08

5.  Rural-urban disparities of breast cancer patients in China.

Authors:  Yan Zhang; Yulan Bu; Hua Gao
Journal:  Med Oncol       Date:  2012-12-29       Impact factor: 3.064

6.  Global breast cancer mortality statistics.

Authors:  C Mettlin
Journal:  CA Cancer J Clin       Date:  1999 May-Jun       Impact factor: 508.702

7.  Esophageal cancer mortality trends in rural and urban China between 1987 and 2009.

Authors:  Bill Guo; Zheng-Liang Huang
Journal:  Asian Pac J Cancer Prev       Date:  2011

8.  Cancer statistics: updated cancer burden in China.

Authors:  Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2015-02       Impact factor: 5.087

9.  Traffic air pollution and risk of death from ovarian cancer in Taiwan: fine particulate matter (PM2.5) as a proxy marker.

Authors:  Li-Ju Hung; Te-Fu Chan; Chen-Hsuan Wu; Hui-Fen Chiu; Chun-Yuh Yang
Journal:  J Toxicol Environ Health A       Date:  2012

10.  Annual report on status of cancer in China, 2010.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Hongmei Zeng; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.